Although PD-L1 expression has been utilized as a predictive biomarker for treatment effectiveness of anti-PD-(L)-1 therapy in other cancers, such as lung cancer [82] and gastroesophageal cancer [83], its prognostic and predictive value in HCC has been less conclusive. The gene discussed is CD274; the disease is hepatocellular carcinoma.